Product Type: | Recombinant Rabbit monoclonal IgG, primary antibodies |
---|---|
Species reactivity: | Human, Mouse |
Applications: | WB, IHC-P, FC, IP |
Clonality: | Monoclonal |
Clone number: | JB71-31 |
Form: | Liquid |
Storage condition: | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
Storage buffer: | 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide. |
Concentration: | 1ug/ul |
Purification: | Protein A affinity purified. |
Molecular weight: | Predicted band size: 42 kDa |
Isotype: | IgG |
Immunogen: | Recombinant protein within Human Biglycan aa 260-368 / 368. |
Positive control: | Mouse skeletal muscle tissue lysates, mouse heart tissue, human kidney tissue, HepG2. |
Subcellular location: | Secreted, extracellular space, extracellular matrix. |
Recommended Dilutions:
WB IHC-P FC IP |
1:1,000 1:50-1:200 1:50-1:100 Use at an assay dependent concentration. |
Uniprot #: | SwissProt: P21810 Human | P28653 Mouse |
Alternative names: | BGN Biglycan Biglycan proteoglycan Bone/cartilage proteoglycan I Dermatan sulphate proteoglycan I DSPG1 PG S1 PG-S1 PGI PGS1_HUMAN SEMDX SLRR1A Small leucine rich protein 1A |
Fig1:
Western blot analysis of Biglycan on mouse skeletal muscle tissue lysates with Rabbit anti-Biglycan antibody (ET7107-48) at 1/1,000 dilution. Lysates/proteins at 5 µg/Lane. Predicted band size: 42 kDa Observed band size: 42 kDa Exposure time: 20 seconds; ECL: K1801; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET7107-48) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. |
|
Fig2: Immunohistochemical analysis of paraffin-embedded mouse heart tissue using anti-Biglycan antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET7107-48, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. | |
Fig3: Immunohistochemical analysis of paraffin-embedded human kidney tissue using anti-Biglycan antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET7107-48, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. |
Fig4: Flow cytometric analysis of Biglycan was done on HepG2 cells. The cells were fixed, permeabilized and stained with the primary antibody (ET7107-48, 1/50) (red). After incubation of the primary antibody at room temperature for an hour, the cells were stained with a Alexa Fluor®488 conjugate-Goat anti-Rabbit IgG Secondary antibody at 1/1,000 dilution for 30 minutes.Unlabelled sample was used as a control (cells without incubation with primary antibody; black). |